MoneyWorks4Me

AstraZeneca Pharma India board to consider unaudited financial results

23 Jan 2013 Evaluate

AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on February 06, 2013, to consider and approve the unaudited financial results of the company for the third quarter and nine months ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..